Apelin–APJ Induces ICAM-1, VCAM-1 and MCP-1 Expression Via NF-κB/JNK Signal Pathway in Human Umbilical Vein Endothelial Cells

Ying Lu,Xiao Zhu,Gan-Xiong Liang,Rong-Rong Cui,Yuan Liu,Shan-Shan Wu,Qiu-Hua Liang,Guan-Ying Liu,Yi Jiang,Xiao-Bo Liao,Hui Xie,Hou-De Zhou,Xian-Ping Wu,Ling-Qing Yuan,Er-Yuan Liao

DOI: https://doi.org/10.1007/s00726-012-1298-7

IF: 3.7891

2012-01-01

Amino Acids

Abstract:Apelin receptor (APJ) deficiency has been reported to be preventive against atherosclerosis. However, the mechanism of this effect remains unknown. In this study, quantitative real-time RT-PCR, Western blotting and ELISA analyses revealed a significant increase in the expression of intercellular adhesion molecule-1(ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical vein endothelial cells (HUVECs) treated with apelin. Inhibitors of cellular signal transduction molecules were used to demonstrate involvement of nuclear factor kappa-B (NF-κB) and c-Jun N-terminal kinase (JNK) pathways in apelin–APJ-induced activation of adhesion molecules and chemokines. Inhibition of APJ expression by RNA interference abrogated apelin-induced expression of adhesion molecules and chemokines and apelin-stimulated cellular signal transduction in HUVECs. The apelin–APJ system in endothelial cells is involved in the expression of adhesion molecules and chemokines, which are important for the initiation of endothelial inflammation-related atherosclerosis. Therefore, apelin–APJ and the cell signaling pathways activated by this system in endothelial cells may represent targets for therapy of atherosclerosis.